,Set,NGenes,Direction,PValue,FDR
1,WP_COMPLEMENT_ACTIVATION,11,Down,9.66798454644589e-05,0.0716910368193945
2,WP_PROSTAGLANDIN_SIGNALING,24,Up,0.000250186567113921,0.0716910368193945
3,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.000260694679343253,0.0716910368193945
4,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.000525586798416635,0.0868931726723094
5,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.000588324159985796,0.0868931726723094
6,WP_TYPE_II_INTERFERON_SIGNALING,31,Up,0.000631950346707705,0.0868931726723094
7,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Up,0.000937926762688314,0.0989744938156123
8,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.000959752667302908,0.0989744938156123
9,WP_PEPTIDE_GPCRS,14,Up,0.00176616589223347,0.147588476326307
10,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.00179948225499302,0.147588476326307
11,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.00196784635101743,0.147588476326307
12,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.00235428696636617,0.156168494752454
13,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Up,0.00257902814359953,0.156168494752454
14,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.00298594585323422,0.156168494752454
15,WP_PRION_DISEASE_PATHWAY,29,Up,0.00336644696142538,0.156168494752454
16,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.00345141149520258,0.156168494752454
17,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Up,0.00366006595829458,0.156168494752454
18,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.00383759656208759,0.156168494752454
19,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.00396481850974896,0.156168494752454
20,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.00399087486284768,0.156168494752454
21,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.00402317835723068,0.156168494752454
22,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Up,0.00436736210478594,0.156168494752454
23,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.00460824511347571,0.156168494752454
24,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.00473237862886223,0.156168494752454
25,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.00473237862886223,0.156168494752454
26,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.00565902466749995,0.167870178102476
27,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Up,0.00568659997975276,0.167870178102476
28,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.00569741210529616,0.167870178102476
29,WP_ENDOTHELIN_PATHWAYS,12,Up,0.00607281641166464,0.172761156538735
30,WP_ESTROGEN_METABOLISM_WP5276,9,Down,0.00639311193986676,0.175810578346336
31,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Up,0.0069387417815995,0.184660063542567
32,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.00724898855672087,0.18688798622796
33,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Up,0.00834932278952756,0.208733069738189
34,WP_MEVALONATE_PATHWAY,7,Up,0.00880263727287621,0.21003413102322
35,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.00891053889189419,0.21003413102322
36,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.00934930821736199,0.214254979981212
37,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Up,0.00978383760476423,0.218153135781905
38,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Up,0.0100590558813578,0.218387397424215
39,WP_MATRIX_METALLOPROTEINASES,10,Up,0.0107007573086419,0.226362173836655
40,WP_CCL18_SIGNALING,23,Up,0.0111350696187873,0.227568649222897
41,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.0118356943474406,0.227568649222897
42,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Up,0.0118424020397599,0.227568649222897
43,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Up,0.0119406158647692,0.227568649222897
44,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.0125241610311645,0.227568649222897
45,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.0128262689014168,0.227568649222897
46,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Up,0.0134355169052162,0.227568649222897
47,WP_PURINERGIC_SIGNALING,16,Up,0.0137193426432553,0.227568649222897
48,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.0137294972558013,0.227568649222897
49,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Up,0.013829015354955,0.227568649222897
50,WP_LUNG_FIBROSIS,35,Up,0.0138321894492397,0.227568649222897
51,WP_NRXN1_DELETION_SYNDROME,2,Down,0.0140678801337791,0.227568649222897
52,WP_SMALL_LIGAND_GPCRS,7,Up,0.01461013900678,0.231795474626799
53,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,0.0155675801589306,0.240523522376177
54,WP_TAMOXIFEN_METABOLISM,3,Down,0.0157433578282588,0.240523522376177
55,WP_PPAR_SIGNALING,37,Down,0.0161155851958834,0.241733777938252
56,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0181521153085222,0.267419555884479
57,WP_BLADDER_CANCER,30,Up,0.0186880650501563,0.270305905697975
58,WP_FOCAL_ADHESION,117,Up,0.0191968775780585,0.270305905697975
59,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Up,0.0195315992578574,0.270305905697975
60,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.0198918927700624,0.270305905697975
61,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.0199862548455472,0.270305905697975
62,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.020655774120593,0.272097565989611
63,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.0207783595846612,0.272097565989611
64,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Up,0.0218896857449479,0.282171730305969
65,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Up,0.0230583983385417,0.292664286604567
66,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.0236947248923132,0.293511979201543
67,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.0238367304321253,0.293511979201543
68,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.0243320726940375,0.295205293714425
69,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.0254171086862534,0.299994940710163
70,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.0254541161814684,0.299994940710163
71,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Up,0.0277695426690991,0.322674263408546
72,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.0292599092197938,0.333378734952755
73,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.030077155223205,0.333378734952755
74,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Up,0.0302626319836591,0.333378734952755
75,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Up,0.0304080901267195,0.333378734952755
76,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0307112531592841,0.333378734952755
77,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.0312477658244079,0.334797490975799
78,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.0318607383485666,0.336988578686762
79,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.0324810168665382,0.339066615225377
80,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.0328791869309456,0.339066615225377
81,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.035224700704391,0.351923882167505
82,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.0352601639103471,0.351923882167505
83,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.0358069670497175,0.351923882167505
84,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.0358322498206915,0.351923882167505
85,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0362753749774178,0.352084521839643
86,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.0367415161607629,0.352462218984063
87,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.0382873942879127,0.363070118247448
88,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Up,0.0389090027351978,0.36477190064248
89,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Up,0.0399919717593068,0.367206870186358
90,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.0405536056882195,0.367206870186358
91,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.0412254792075883,0.367206870186358
92,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.0412254792075883,0.367206870186358
93,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.0413942290028258,0.367206870186358
94,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,81,Down,0.0420814899763194,0.369332225855995
95,WP_NUCLEOTIDE_GPCRS,7,Up,0.0442886463186747,0.384611928556912
96,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.0451461185817806,0.387356511165178
97,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.0455437352521482,0.387356511165178
98,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Up,0.0463324714444497,0.390043764710928
99,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.047233730530693,0.393614421089109
100,WP_MELANOMA,53,Up,0.0480910925815472,0.396751513797764
101,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.0501717842756377,0.399152384448678
102,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.0506031112772457,0.399152384448678
103,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.0509843869875003,0.399152384448678
104,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.0510782450290269,0.399152384448678
105,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.051469243121269,0.399152384448678
106,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.0517859743298652,0.399152384448678
107,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.0523074974401115,0.399152384448678
108,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.0527180335416282,0.399152384448678
109,WP_POSTCOVID_NEUROINFLAMMATION,13,Up,0.0530170653959912,0.399152384448678
110,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.0532291885646702,0.399152384448678
111,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.0537671917713134,0.399152384448678
112,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.0541879600706084,0.399152384448678
113,WP_GPR40_PATHWAY,7,Down,0.0554643260201086,0.404938663421147
114,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.0575645315974853,0.413989693363659
115,WP_NEOVASCULARIZATION_PROCESSES,23,Up,0.0577076542264494,0.413989693363659
116,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.0586962080433311,0.417451479618519
117,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Up,0.0645075464275478,0.454860904296811
118,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.0669882733338042,0.46543851175159
119,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.0676178935878651,0.46543851175159
120,WP_LUNG_PATHOLOGY_OF_COVID19,16,Up,0.0681001088039041,0.46543851175159
121,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.0682643150568999,0.46543851175159
122,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.0695006603239105,0.469983973501854
123,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.0707915020298358,0.474821050200118
124,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.0713967771121666,0.475018879980141
125,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.0740935795070431,0.489017624746485
126,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Up,0.0748503471108391,0.490091558463827
127,WP_CHEMOKINE_SIGNALING,115,Up,0.0766954368894515,0.4982183892425
128,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.0790742524897462,0.503532053122125
129,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0792286132757667,0.503532053122125
130,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.0793565401622628,0.503532053122125
131,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.0799547866169678,0.503532053122125
132,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.0812022910135778,0.50557775307996
133,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.0815052620116785,0.50557775307996
134,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Up,0.082490711284033,0.507871916487517
135,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.0840082333523657,0.513383648264457
136,WP_NOTCH_SIGNALING_WP61,49,Up,0.0848636775648733,0.514798044051621
137,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.0861762742363101,0.518944717116466
138,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.0873644861397883,0.520717793075655
139,WP_STEROID_BIOSYNTHESIS,2,Down,0.0883783941239258,0.520717793075655
140,WP_KLEEFSTRA_SYNDROME,25,Down,0.0889500936746248,0.520717793075655
141,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.0892208351272313,0.520717793075655
142,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.0896265777172642,0.520717793075655
143,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.0926417398931237,0.534471576306483
144,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.0957360178884533,0.539936153670563
145,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Up,0.096159374220714,0.539936153670563
146,WP_SULINDAC_METABOLIC_PATHWAY,3,Down,0.0962019351500285,0.539936153670563
147,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.0962068055631184,0.539936153670563
148,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Up,0.0978453945788261,0.545421963023862
149,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.0986992550451927,0.546489163840832
150,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.100523930967444,0.549285392196205
151,WP_OSTEOPONTIN_SIGNALING,12,Up,0.100550734641523,0.549285392196205
152,WP_MEASLES_VIRUS_INFECTION,99,Up,0.10213071859996,0.549285392196205
153,WP_ECTODERM_DIFFERENTIATION,72,Up,0.102648144413686,0.549285392196205
154,WP_IL26_SIGNALING,33,Up,0.102777517775168,0.549285392196205
155,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.103554340215256,0.549285392196205
156,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Up,0.103864874160737,0.549285392196205
157,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.105933842106884,0.552722715646146
158,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.105933842106884,0.552722715646146
159,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Up,0.107091491346096,0.552722715646146
160,WP_PROTEASOME_DEGRADATION,57,Up,0.108028322200351,0.552722715646146
161,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.108788044632875,0.552722715646146
162,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.109194017203187,0.552722715646146
163,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.109280736988269,0.552722715646146
164,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.110620907651639,0.552722715646146
165,WP_VITAMIN_B12_DISORDERS,9,Up,0.111434253103856,0.552722715646146
166,WP_CILIOPATHIES,116,Down,0.112241718066233,0.552722715646146
167,WP_SPINAL_CORD_INJURY,65,Up,0.112337974067958,0.552722715646146
168,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Up,0.112554443913397,0.552722715646146
169,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.113798294635559,0.552915816638969
170,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Down,0.113934168277121,0.552915816638969
171,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.116139643087988,0.558856663355972
172,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.116513146784518,0.558856663355972
173,WP_IRINOTECAN_PATHWAY,5,Down,0.117426774497291,0.559983173180724
174,WP_ZINC_HOMEOSTASIS,20,Up,0.118592176782082,0.560951755085487
175,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.118989766230255,0.560951755085487
176,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Up,0.120352204486938,0.561094294391154
177,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.120380230433011,0.561094294391154
178,WP_HEPATITIS_B_INFECTION,118,Up,0.121537891474829,0.561195875932923
179,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.122091697969652,0.561195875932923
180,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.122912700034806,0.561195875932923
181,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.124373782682565,0.561195875932923
182,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.125053525019263,0.561195875932923
183,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.126584338075565,0.561195875932923
184,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Up,0.127077366349759,0.561195875932923
185,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.127775786149027,0.561195875932923
186,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.127934907712086,0.561195875932923
187,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.128985564685677,0.561195875932923
188,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Up,0.129243394367947,0.561195875932923
189,WP_BENZOAPYRENE_METABOLISM,4,Down,0.129387233222356,0.561195875932923
190,WP_OSTEOBLAST_SIGNALING,3,Up,0.129760379098947,0.561195875932923
191,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Up,0.130168874466104,0.561195875932923
192,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.1314643499483,0.561195875932923
193,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.132758203560907,0.561195875932923
194,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.132919239334992,0.561195875932923
195,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.133592083730181,0.561195875932923
196,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,39,Up,0.13382790505464,0.561195875932923
197,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.134699321962801,0.561195875932923
198,WP_RETINOL_METABOLISM,5,Up,0.135378886002019,0.561195875932923
199,WP_10Q22Q23_COPY_NUMBER_VARIATION,25,Up,0.135394040191965,0.561195875932923
200,WP_SEROTONIN_AND_ANXIETY,6,Up,0.136047485074648,0.561195875932923
201,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.136782239619618,0.561419640229774
202,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.139850294946456,0.571170759063496
203,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.140611722695755,0.571451582384224
204,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.141777992442887,0.573366881202851
205,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.144022981720267,0.579604682532781
206,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.145362732822925,0.581431111790664
207,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.145886351685657,0.581431111790664
208,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.146698771523397,0.581434291680612
209,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Up,0.147296687225755,0.581434291680612
210,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.14808582240041,0.581765730858752
211,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.148963419803822,0.582439911555227
212,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.150013870146813,0.583204440862458
213,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Up,0.151132206235569,0.583204440862458
214,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.152079870662214,0.583204440862458
215,WP_VEGFAVEGFR2_SIGNALING,338,Up,0.152622273021794,0.583204440862458
216,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.152693526334898,0.583204440862458
217,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.154157074124107,0.58582046695148
218,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.154798620358088,0.58582046695148
219,WP_WNT_SIGNALING_WP428,59,Up,0.156958002392892,0.591280146000622
220,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.158293124716479,0.593599217686796
221,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Up,0.159029142351759,0.593660825521273
222,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.163118818573009,0.604255632019612
223,WP_CELL_CYCLE,88,Up,0.163332128412574,0.604255632019612
224,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Up,0.166813326096999,0.614379437634037
225,WP_INTERFERONMEDIATED_SIGNALING,14,Up,0.168664260829691,0.618435623042199
226,WP_HEART_DEVELOPMENT,15,Up,0.170116272904809,0.618975609035965
227,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.170312076668078,0.618975609035965
228,WP_OSTEOCLAST_SIGNALING,9,Up,0.171321375878221,0.619912873243562
229,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.175490070341275,0.628223018373061
230,WP_PLEURAL_MESOTHELIOMA,247,Up,0.176177239570795,0.628223018373061
231,WP_FOXA2_PATHWAY,9,Down,0.176340431792992,0.628223018373061
232,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.17666392759097,0.628223018373061
233,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Up,0.179704220708188,0.633337590456782
234,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,94,Up,0.180300622827945,0.633337590456782
235,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.180405253039205,0.633337590456782
236,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.182819075454595,0.638990638162816
237,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.185085322711133,0.638990638162816
238,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.185151766172448,0.638990638162816
239,WP_JOUBERT_SYNDROME,66,Down,0.185664744983262,0.638990638162816
240,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.186644751639604,0.638990638162816
241,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.186662719754229,0.638990638162816
242,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.190202408997824,0.644118622306218
243,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Up,0.190695150951409,0.644118622306218
244,WP_BARDETBIEDL_SYNDROME,62,Down,0.191024315075307,0.644118622306218
245,WP_SLEEP_REGULATION,10,Down,0.19202968950252,0.644118622306218
246,WP_CAMKK2_PATHWAY,29,Up,0.192064461924036,0.644118622306218
247,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.194616540955957,0.646586450287288
248,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.195578300049794,0.646586450287288
249,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.195915613821907,0.646586450287288
250,WP_BREAST_CANCER_PATHWAY,83,Up,0.196096051639445,0.646586450287288
251,WP_IL7_SIGNALING,24,Up,0.196719029117708,0.646586450287288
252,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.199617150394679,0.653508528077817
253,WP_GASTRIC_CANCER_NETWORK_1,16,Down,0.203982184020134,0.661658911447602
254,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.204332217515806,0.661658911447602
255,WP_APOPTOSIS,69,Up,0.205662454980932,0.661658911447602
256,WP_EICOSANOID_SYNTHESIS,13,Down,0.205916555536707,0.661658911447602
257,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.20611677605095,0.661658911447602
258,WP_RAC1PAK1P38MMP2_PATHWAY,52,Up,0.210188379333738,0.665002429543005
259,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Up,0.210435238152557,0.665002429543005
260,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.210448870941449,0.665002429543005
261,WP_MACROPHAGE_MARKERS,8,Down,0.210740507298689,0.665002429543005
262,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.21170019708746,0.665002429543005
263,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.212099895858663,0.665002429543005
264,WP_PI3KAKT_SIGNALING,175,Up,0.214398612381773,0.665002429543005
265,WP_ALSTROM_SYNDROME,27,Down,0.215057418375255,0.665002429543005
266,WP_METHYLATION_PATHWAYS,5,Up,0.217661691816515,0.665002429543005
267,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Up,0.218884259503524,0.665002429543005
268,WP_CANCER_PATHWAYS,294,Up,0.219214452661566,0.665002429543005
269,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.219738182041135,0.665002429543005
270,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.220202216876871,0.665002429543005
271,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.223510244490488,0.665002429543005
272,WP_BURN_WOUND_HEALING,62,Up,0.224832893374998,0.665002429543005
273,WP_IL19_SIGNALING,20,Up,0.225355794743289,0.665002429543005
274,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Up,0.225767486237894,0.665002429543005
275,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.22656870743941,0.665002429543005
276,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.227753541566421,0.665002429543005
277,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Up,0.228121207950544,0.665002429543005
278,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.228262488848126,0.665002429543005
279,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.2283218217198,0.665002429543005
280,WP_ENDOMETRIAL_CANCER,48,Up,0.228648015583236,0.665002429543005
281,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.23009385465797,0.665002429543005
282,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.230210450960824,0.665002429543005
283,WP_BENZENE_METABOLISM,3,Down,0.230609554379154,0.665002429543005
284,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.231022228747929,0.665002429543005
285,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.231730964839538,0.665002429543005
286,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.232341365625177,0.665002429543005
287,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.233311449514175,0.665002429543005
288,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.23373459647892,0.665002429543005
289,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.23373459647892,0.665002429543005
290,WP_ADIPOGENESIS,80,Up,0.233758429778753,0.665002429543005
291,WP_PREIMPLANTATION_EMBRYO,20,Up,0.23641184896705,0.668311041621815
292,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Up,0.237690175062427,0.668311041621815
293,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.237745908990103,0.668311041621815
294,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.238786168557927,0.668311041621815
295,WP_SMALL_CELL_LUNG_CANCER,64,Up,0.238971827004164,0.668311041621815
296,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.241222443281683,0.67061719166699
297,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.241422189000116,0.67061719166699
298,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.242673036339759,0.671829714698997
299,WP_ENERGY_METABOLISM,41,Up,0.244147646783585,0.673651533767418
300,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.247164854365645,0.679564605948859
301,WP_HUNGER_AND_SATIETY,2,Down,0.248265219784747,0.679564605948859
302,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Up,0.248761831510976,0.679564605948859
303,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.249721365438844,0.679694049920469
304,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,6,Down,0.250456959000997,0.679694049920469
305,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Up,0.254781669510309,0.688723696501385
306,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Up,0.255453880156877,0.688723696501385
307,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.256468828600671,0.689207764154897
308,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.258305464754388,0.689967681090083
309,WP_IL17_SIGNALING,24,Up,0.258455828483089,0.689967681090083
310,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.259260583197486,0.689967681090083
311,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Up,0.261511307611555,0.693719706686601
312,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.266723176412701,0.700017407959849
313,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.267063610805076,0.700017407959849
314,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.267643538499117,0.700017407959849
315,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.267860908944743,0.700017407959849
316,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Up,0.268127879897348,0.700017407959849
317,WP_TAR_SYNDROME,45,Up,0.269989213042844,0.701455103643392
318,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.270416588567702,0.701455103643392
319,WP_GASTRIN_SIGNALING,91,Up,0.271229306742112,0.701455103643392
320,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.27243604499083,0.702374178491984
321,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Up,0.27432726699569,0.705046714241259
322,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.27561511415997,0.706156736589984
323,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.277213459355073,0.7080529534611
324,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.279147576003623,0.709242060061288
325,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.279398387296871,0.709242060061288
326,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.280626742917562,0.70987787914644
327,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.28172996416654,0.70987787914644
328,WP_PHOSPHOINOSITIDES_METABOLISM,37,Down,0.282230235587918,0.70987787914644
329,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.286693054776084,0.717220409370381
330,WP_PYRIMIDINE_METABOLISM,70,Up,0.286888163748153,0.717220409370381
331,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Down,0.288048802624157,0.71794641137441
332,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.289802289511027,0.720141231465654
333,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.29287643198875,0.723439593808892
334,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.292883423432933,0.723439593808892
335,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.29589868687785,0.724576797278716
336,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.296412528343141,0.724576797278716
337,WP_SPHINGOLIPID_PATHWAY,21,Up,0.299794002407607,0.724576797278716
338,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.300314376918229,0.724576797278716
339,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.30040958618511,0.724576797278716
340,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.302400422418412,0.724576797278716
341,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.303320849754371,0.724576797278716
342,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.304966259777051,0.724576797278716
343,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.305217863395066,0.724576797278716
344,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Up,0.305924774845755,0.724576797278716
345,WP_WNT_SIGNALING_WP363,40,Up,0.306896849062133,0.724576797278716
346,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.306989034559975,0.724576797278716
347,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.307255227302396,0.724576797278716
348,WP_IL5_SIGNALING,37,Up,0.307602398135586,0.724576797278716
349,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.307810691302225,0.724576797278716
350,WP_KREBS_CYCLE_DISORDERS,11,Down,0.308917295371045,0.724576797278716
351,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.309577092550192,0.724576797278716
352,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Up,0.309824399124205,0.724576797278716
353,WP_TGFB_SMAD_SIGNALING,6,Up,0.310260068072274,0.724576797278716
354,WP_NAD_METABOLISM,11,Down,0.311023716329165,0.724576797278716
355,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.311787591556296,0.724576797278716
356,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.314128618276071,0.726339829736197
357,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.315051506320922,0.726339829736197
358,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.315365103420003,0.726339829736197
359,WP_MAPK_SIGNALING,157,Up,0.3160678774246,0.726339829736197
360,WP_COMPLEMENT_SYSTEM,53,Down,0.317272151970554,0.726686757705131
361,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.317980508523094,0.726686757705131
362,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Up,0.324469948694833,0.73524232671238
363,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.325459874397046,0.73524232671238
364,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.325635744840977,0.73524232671238
365,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.326001432314182,0.73524232671238
366,WP_DNA_DAMAGE_RESPONSE,57,Up,0.32618023221422,0.73524232671238
367,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.327703250047951,0.735489768345976
368,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.328073011819781,0.735489768345976
369,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.329712733438886,0.735577403390981
370,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.33092098367457,0.735577403390981
371,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Up,0.332575935178034,0.735577403390981
372,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.33363841889203,0.735577403390981
373,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.334385296885516,0.735577403390981
374,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.336053553045392,0.735577403390981
375,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.336167518296301,0.735577403390981
376,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.3366629362671,0.735577403390981
377,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Up,0.336799177665339,0.735577403390981
378,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.337508796599086,0.735577403390981
379,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.337919801072948,0.735577403390981
380,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.339988419028093,0.738132751837307
381,WP_15Q11Q13_COPY_NUMBER_VARIATION,29,Down,0.340979260004927,0.738340917333503
382,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.345903512117604,0.747042925384877
383,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.348795197164161,0.751321247155177
384,WP_IL2_SIGNALING,37,Up,0.352457707683714,0.757233356351729
385,WP_CYTOSINE_METHYLATION,7,Up,0.355337887181755,0.76143832967519
386,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.359778498757899,0.768956635946287
387,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.361368078711985,0.770358307331751
388,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.363239706272106,0.772352468233214
389,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.36679470846786,0.77605380519849
390,WP_SERINE_METABOLISM,7,Up,0.368947171243448,0.77605380519849
391,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.369947081011228,0.77605380519849
392,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.371866974939748,0.77605380519849
393,WP_ALZHEIMERS_DISEASE,183,Up,0.374184669318003,0.77605380519849
394,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.374184669318003,0.77605380519849
395,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.374210957405349,0.77605380519849
396,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.374972700191394,0.77605380519849
397,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.375413708649413,0.77605380519849
398,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.37570513031565,0.77605380519849
399,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.378498015506017,0.77605380519849
400,WP_GASTRIC_CANCER_NETWORK_2,25,Up,0.379010309462878,0.77605380519849
401,WP_COPPER_HOMEOSTASIS,39,Up,0.37915467409465,0.77605380519849
402,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.382393069134828,0.77605380519849
403,WP_VITAMIN_B12_METABOLISM,24,Up,0.3833038937939,0.77605380519849
404,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.38454270495404,0.77605380519849
405,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.385387741602327,0.77605380519849
406,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.387105433100099,0.77605380519849
407,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.387192698594364,0.77605380519849
408,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.388418628502834,0.77605380519849
409,WP_KININKALLIKREIN_PATHWAY,2,Up,0.389074764378156,0.77605380519849
410,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.389378637717813,0.77605380519849
411,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Up,0.390035649743995,0.77605380519849
412,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.390296155653205,0.77605380519849
413,WP_NUCLEAR_RECEPTORS,21,Down,0.390406441464206,0.77605380519849
414,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.39046576247392,0.77605380519849
415,WP_G13_SIGNALING,30,Up,0.390883594483326,0.77605380519849
416,WP_SPINA_BIFIDA,10,Down,0.393042529364374,0.77605380519849
417,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.393186214994861,0.77605380519849
418,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.393200594633901,0.77605380519849
419,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.396898102169617,0.776296782423301
420,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.397259747639755,0.776296782423301
421,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.397664054907018,0.776296782423301
422,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.398691652791052,0.776296782423301
423,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.398925518714301,0.776296782423301
424,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.399812527700541,0.776296782423301
425,WP_ENDODERM_DIFFERENTIATION,82,Up,0.401491226961381,0.776296782423301
426,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.402992421198675,0.776296782423301
427,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.403417508099275,0.776296782423301
428,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.40386891784001,0.776296782423301
429,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.404523688346475,0.776296782423301
430,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.405469309432096,0.776296782423301
431,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.40555625845387,0.776296782423301
432,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.40984917297066,0.780130724188058
433,WP_TYPE_II_DIABETES_MELLITUS,12,Down,0.409957171242691,0.780130724188058
434,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.411270436464907,0.780130724188058
435,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.413197722549381,0.780130724188058
436,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.414035553920874,0.780130724188058
437,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.414256005741717,0.780130724188058
438,WP_PDGF_PATHWAY,36,Up,0.414304639676929,0.780130724188058
439,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.415813761591147,0.780130724188058
440,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Up,0.416971426570752,0.780130724188058
441,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.417542359766036,0.780130724188058
442,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.419221972460819,0.780130724188058
443,WP_IL3_SIGNALING,45,Up,0.4193300896509,0.780130724188058
444,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.421601454013114,0.780130724188058
445,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.422686672507819,0.780130724188058
446,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.423322355733403,0.780130724188058
447,WP_TRANSLATION_FACTORS,49,Down,0.423382475632037,0.780130724188058
448,WP_AMINO_ACID_METABOLISM,57,Down,0.423634623559091,0.780130724188058
449,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.42461655271076,0.780197452085473
450,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.426372334441742,0.781682613143193
451,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.427506353262768,0.782023816944088
452,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.429209491322039,0.782329707446943
453,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.429570130270867,0.782329707446943
454,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.432426896444084,0.785284531008135
455,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.433096317101456,0.785284531008135
456,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.436487192836556,0.789697223881927
457,WP_MIRNA_BIOGENESIS,6,Up,0.441422568779277,0.795748397734483
458,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.442336643681336,0.795748397734483
459,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.442725472194094,0.795748397734483
460,WP_MONOAMINE_GPCRS,3,Up,0.44481053330459,0.796389425004113
461,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.445012757487147,0.796389425004113
462,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.44603571337078,0.796492345304964
463,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.44808624960391,0.79842582272835
464,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.449242165178399,0.798760315241766
465,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.451524077561037,0.799477757273348
466,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.451583799865915,0.799477757273348
467,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.453833993734754,0.801740995355829
468,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.456559253114375,0.803495168933365
469,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.456853762675989,0.803495168933365
470,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.458208167959635,0.803495168933365
471,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.459416182431524,0.803495168933365
472,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Down,0.459696629983695,0.803495168933365
473,WP_BDNFTRKB_SIGNALING,26,Down,0.464389761802837,0.805628298439445
474,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.464495461271123,0.805628298439445
475,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.464495461271123,0.805628298439445
476,WP_TYPE_III_INTERFERON_SIGNALING,6,Up,0.464823115220819,0.805628298439445
477,WP_DRAVET_SYNDROME,12,Up,0.466682987244245,0.807156110013631
478,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.468686023564198,0.808378809199274
479,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.469349635886609,0.808378809199274
480,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.470366186796015,0.808441883555651
481,WP_NEPHROGENESIS,3,Down,0.473585410675286,0.80951687511138
482,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Up,0.474164113450694,0.80951687511138
483,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.474295670782681,0.80951687511138
484,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.476227679505566,0.80951687511138
485,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.477170401788812,0.80951687511138
486,WP_NPHP1_DELETION_SYNDROME,10,Down,0.477777639937254,0.80951687511138
487,WP_ANGIOGENESIS,14,Up,0.477860264459688,0.80951687511138
488,WP_DOPAMINE_METABOLISM,7,Up,0.480755498440964,0.811192205825289
489,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.481296048709814,0.811192205825289
490,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Up,0.481799007096232,0.811192205825289
491,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.483909926032908,0.811490491752907
492,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.483943420536279,0.811490491752907
493,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Up,0.486543081006561,0.814194811015036
494,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.48774918351473,0.814560883400106
495,WP_AGERAGE_PATHWAY,55,Up,0.489460960992318,0.81576826832053
496,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.491050089465824,0.816766781873599
497,WP_ATM_SIGNALING,33,Down,0.496139466299083,0.820709384285251
498,WP_TNFALPHA_SIGNALING,81,Up,0.497151478959185,0.820709384285251
499,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.497557635883169,0.820709384285251
500,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.497959006228321,0.820709384285251
501,WP_PDGFRBETA_PATHWAY,27,Up,0.498394426093225,0.820709384285251
502,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.499658642905654,0.821152152185587
503,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.502697092731348,0.822319236549335
504,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.502754751429431,0.822319236549335
505,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.503359047827169,0.822319236549335
506,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.504622198751444,0.822753584920833
507,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.50641410308829,0.82404661745136
508,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,164,Down,0.510203599890759,0.827630754521946
509,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.511098987555925,0.827630754521946
510,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.511770147769783,0.827630754521946
511,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.514136350626822,0.827630754521946
512,WP_MONOAMINE_TRANSPORT,11,Up,0.514549013797764,0.827630754521946
513,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.514635850993646,0.827630754521946
514,WP_NRF2_PATHWAY,69,Up,0.518933868145609,0.83291914634266
515,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.520799946349858,0.834291176191521
516,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.522031152425562,0.834642830912962
517,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.523383824653151,0.834725600776144
518,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.524527287886992,0.834725600776144
519,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.525984368298348,0.834725600776144
520,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.526823653437059,0.834725600776144
521,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.530452873097545,0.834725600776144
522,WP_THERMOGENESIS,74,Up,0.530455744638289,0.834725600776144
523,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.530767283103229,0.834725600776144
524,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.531273787649283,0.834725600776144
525,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.53271619108955,0.834725600776144
526,WP_NUCLEAR_RECEPTORS_METAPATHWAY,176,Up,0.533047211285357,0.834725600776144
527,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.533773649156933,0.834725600776144
528,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.534224384496732,0.834725600776144
529,WP_NRF2ARE_REGULATION,21,Up,0.536036735719839,0.835642525467557
530,WP_FERROPTOSIS,48,Up,0.536837016360976,0.835642525467557
531,WP_INSULIN_SIGNALING,127,Down,0.539315106070927,0.83582424238657
532,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.53974454425245,0.83582424238657
533,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.540556492935179,0.83582424238657
534,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.542090008240634,0.83582424238657
535,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.544078841402342,0.83582424238657
536,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Up,0.544298952160031,0.83582424238657
537,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Down,0.546975104750462,0.83582424238657
538,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Up,0.547572477095436,0.83582424238657
539,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.547830208237593,0.83582424238657
540,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.54849588026788,0.83582424238657
541,WP_RAS_SIGNALING,114,Up,0.548596366297324,0.83582424238657
542,WP_OVARIAN_INFERTILITY,21,Up,0.549111199240632,0.83582424238657
543,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Up,0.550278045870547,0.836057804499449
544,WP_NEUROINFLAMMATION,10,Up,0.556366439883773,0.842441888275249
545,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Up,0.556522217103043,0.842441888275249
546,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.558254272434311,0.843369762390086
547,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.560653041956752,0.843369762390086
548,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.560761765287505,0.843369762390086
549,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.561224241881403,0.843369762390086
550,WP_EGFEGFR_SIGNALING,138,Up,0.562251287906581,0.843376931859871
551,WP_UROTENSINIIMEDIATED_SIGNALING,49,Up,0.564907577736841,0.845823505685833
552,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.566247751208001,0.846294193381523
553,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.57131690854424,0.84832768314745
554,WP_IL11_SIGNALING,40,Up,0.57218552850732,0.84832768314745
555,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.572227674160479,0.84832768314745
556,WP_CREATINE_PATHWAY,2,Down,0.572360508783107,0.84832768314745
557,WP_KALLMANN_SYNDROME,11,Up,0.572749720621975,0.84832768314745
558,WP_CIRCADIAN_RHYTHM_GENES,113,Up,0.574344884225074,0.849165823451051
559,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.575761023411784,0.84973675190469
560,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.580601756794047,0.851368720914516
561,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.580649563865659,0.851368720914516
562,WP_NOTCH_SIGNALING_WP268,34,Up,0.580971171994404,0.851368720914516
563,WP_CORI_CYCLE,11,Down,0.580994654393785,0.851368720914516
564,WP_IRON_METABOLISM_DISORDERS,12,Up,0.584172499373718,0.854507645360491
565,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.585949224338114,0.855589575360963
566,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.587897547134111,0.856352993383915
567,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.588548057271127,0.856352993383915
568,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.590467561058253,0.857633341325807
569,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.595593654836648,0.86051768549806
570,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.596069546774346,0.86051768549806
571,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.596353013207727,0.86051768549806
572,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.596625595278655,0.86051768549806
573,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.598159690454844,0.860620328820999
574,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.598783113628186,0.860620328820999
575,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.604697222047292,0.866293817550856
576,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.606155765666011,0.866293817550856
577,WP_GLUTATHIONE_METABOLISM,10,Up,0.60618377491741,0.866293817550856
578,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.607917260793644,0.866293817550856
579,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.607980751953874,0.866293817550856
580,WP_MTHFR_DEFICIENCY,18,Down,0.612664462557837,0.87021792446021
581,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.612844380741069,0.87021792446021
582,WP_HIPPO_SIGNALING_REGULATION,41,Up,0.61452453045688,0.871104360183722
583,WP_IL1_SIGNALING,51,Up,0.616010019045155,0.871693994487733
584,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.617638490498674,0.871693994487733
585,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.618110287000392,0.871693994487733
586,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.622489236345516,0.876371365162203
587,WP_LEPTIN_SIGNALING,70,Up,0.626937841114156,0.880818740179233
588,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.627783538455017,0.880818740179233
589,WP_MRNA_PROCESSING,124,Up,0.634019410526703,0.886531815430472
590,WP_PPARALPHA_PATHWAY,16,Up,0.63524984208132,0.886531815430472
591,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.635458430155469,0.886531815430472
592,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.636153739072533,0.886531815430472
593,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.641554118839982,0.892518554319387
594,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.642613359109958,0.892518554319387
595,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.644323015220563,0.893389054717588
596,WP_CELLULAR_PROTEOSTASIS,6,Down,0.650681052558963,0.894916270810777
597,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.651635705274125,0.894916270810777
598,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.651800032444525,0.894916270810777
599,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.65197328853405,0.894916270810777
600,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Up,0.652047772662991,0.894916270810777
601,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.653231663624897,0.894916270810777
602,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.653559192915427,0.894916270810777
603,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,270,Up,0.654447246155395,0.894916270810777
604,WP_DNA_REPLICATION,34,Up,0.655187184932981,0.894916270810777
605,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.658322851032492,0.897589170250798
606,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.660055875051782,0.897589170250798
607,WP_PURINE_METABOLISM,10,Down,0.660408031929981,0.897589170250798
608,WP_G_PROTEIN_SIGNALING,62,Up,0.662267160541868,0.898635538564213
609,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.664951857258077,0.900686520094988
610,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.666159291090591,0.900686520094988
611,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.667053895488531,0.900686520094988
612,WP_MALE_INFERTILITY,71,Up,0.671872298483601,0.901491032520425
613,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.67216459158157,0.901491032520425
614,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Down,0.672706877689867,0.901491032520425
615,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.674627013930709,0.901491032520425
616,WP_FRAGILE_X_SYNDROME,83,Down,0.675141453692784,0.901491032520425
617,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.675325505462296,0.901491032520425
618,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.678049748051637,0.901491032520425
619,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.678697741415456,0.901491032520425
620,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.678715130510538,0.901491032520425
621,WP_HEME_BIOSYNTHESIS,8,Up,0.678715130510538,0.901491032520425
622,WP_PROLACTIN_SIGNALING,70,Up,0.679669602700247,0.901491032520425
623,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Up,0.683175178003834,0.904686230903954
624,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.686578500678304,0.90773599849295
625,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.689273809201227,0.90984142814562
626,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.691459433596498,0.910203635837368
627,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.691891582181715,0.910203635837368
628,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Down,0.692858040370748,0.910203635837368
629,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.695453100752913,0.911739977003843
630,WP_BASE_EXCISION_REPAIR,29,Up,0.696237800621117,0.911739977003843
631,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.697570157182545,0.912037051783834
632,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.699004707025987,0.912466587494366
633,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.700142039015547,0.912507396821211
634,WP_IL18_SIGNALING,190,Up,0.703117602143409,0.913629540662333
635,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.703217888873432,0.913629540662333
636,WP_DNA_MISMATCH_REPAIR,21,Down,0.710797932473332,0.921278865152298
637,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.711338954063047,0.921278865152298
638,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.718820554125906,0.929509337231775
639,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.721950923920393,0.932096263277502
640,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.724011042586142,0.933295484583699
641,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Down,0.727969576291125,0.934223944713913
642,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.728870221301729,0.934223944713913
643,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.728905908222063,0.934223944713913
644,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.729285452145163,0.934223944713913
645,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.730393265867241,0.934223944713913
646,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.733531128771374,0.936024144304603
647,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.735142480070957,0.936024144304603
648,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.736273210619703,0.936024144304603
649,WP_AEROBIC_GLYCOLYSIS,10,Down,0.740626419489506,0.936024144304603
650,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.740626419489506,0.936024144304603
651,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.74120604970355,0.936024144304603
652,WP_SILDENAFIL_TREATMENT,11,Up,0.741645387906703,0.936024144304603
653,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.742198894360264,0.936024144304603
654,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Up,0.743162965965806,0.936024144304603
655,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.745112067182113,0.936024144304603
656,WP_VALPROIC_ACID_PATHWAY,8,Down,0.745711377759148,0.936024144304603
657,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.746923174293013,0.936024144304603
658,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.747509917468008,0.936024144304603
659,WP_FOLATE_METABOLISM,36,Down,0.747684740723314,0.936024144304603
660,WP_RETT_SYNDROME,30,Down,0.752008749938969,0.940010937423711
661,WP_ID_SIGNALING,11,Up,0.754551053048439,0.940457816036277
662,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.755654805312198,0.940457816036277
663,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.75578609943279,0.940457816036277
664,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.758552512925166,0.942466884818195
665,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.759685428368606,0.942466884818195
666,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.763901493631016,0.946274372741124
667,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.766817615326395,0.948462567682573
668,WP_ALLOGRAFT_REJECTION,50,Up,0.768762541825053,0.949444755996509
669,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.770548343542712,0.949539744788295
670,WP_IL9_SIGNALING,15,Up,0.773697886799896,0.949539744788295
671,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.7741418637605,0.949539744788295
672,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.77415570199376,0.949539744788295
673,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Up,0.777548929169584,0.949539744788295
674,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.777689904170108,0.949539744788295
675,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Up,0.778013672221901,0.949539744788295
676,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.778246012539288,0.949539744788295
677,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.780515540499795,0.949539744788295
678,WP_MAPK_CASCADE,30,Down,0.781291330578136,0.949539744788295
679,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.782360674624387,0.949539744788295
680,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.783131869892578,0.949539744788295
681,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Down,0.783801898425247,0.949539744788295
682,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.786420403426912,0.950844615760427
683,WP_P38_MAPK_SIGNALING,31,Up,0.787184087956814,0.950844615760427
684,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.792555200562227,0.952421951527724
685,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Up,0.793645069953537,0.952421951527724
686,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Up,0.794077072775599,0.952421951527724
687,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.794178206277206,0.952421951527724
688,WP_HYPERTROPHY_MODEL,13,Up,0.794262185031605,0.952421951527724
689,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.795874787849052,0.952846635783236
690,WP_ERBB_SIGNALING,68,Up,0.797776699568449,0.952846635783236
691,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.798808165745961,0.952846635783236
692,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.800282153264273,0.952846635783236
693,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.800799255692519,0.952846635783236
694,WP_GPCRS_OTHER,13,Up,0.801546139677049,0.952846635783236
695,WP_GLYOXYLATE_METABOLISM,5,Down,0.803282157418998,0.953536373914638
696,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.806183854892673,0.955195862696445
697,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.80816672161169,0.955195862696445
698,WP_TRANSSULFURATION_PATHWAY,8,Down,0.808829876097342,0.955195862696445
699,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.810346625285065,0.955195862696445
700,WP_AUTOPHAGY,27,Down,0.810469216833347,0.955195862696445
701,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.813028338459149,0.956845048828527
702,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.816731276345207,0.957517556768688
703,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.817137441363964,0.957517556768688
704,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.818742993216738,0.957517556768688
705,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.818874099092583,0.957517556768688
706,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Up,0.81940290312569,0.957517556768688
707,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.820889196577376,0.957897577335693
708,WP_IL6_SIGNALING,39,Up,0.825398313864325,0.961798882680888
709,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.828914917672186,0.963317829523966
710,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.829037162378201,0.963317829523966
711,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.830748953042252,0.963949207116537
712,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.83335743066364,0.96558862128088
713,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Up,0.834502650876688,0.96558862128088
714,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.83638032977275,0.965597050580927
715,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.837964050177843,0.965597050580927
716,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Up,0.838021197837508,0.965597050580927
717,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.839349907185747,0.965779181908286
718,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.846148599801856,0.971765960551322
719,WP_ONECARBON_METABOLISM,22,Down,0.846908758347152,0.971765960551322
720,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.848381831663993,0.971968238551232
721,WP_ATR_SIGNALING,10,Down,0.849441333327804,0.971968238551232
722,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.854456826483745,0.976338181285531
723,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.855627278872047,0.976338181285531
724,WP_IDO_METABOLIC_PATHWAY,6,Up,0.859221533406597,0.978785689255249
725,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.862089247762115,0.978785689255249
726,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.862239074884572,0.978785689255249
727,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.862570746622041,0.978785689255249
728,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.86488790794063,0.978785689255249
729,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.865651182157414,0.978785689255249
730,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.866134397774225,0.978785689255249
731,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,14,Up,0.867799946151964,0.978785689255249
732,WP_ASPIRIN_AND_MIRNAS,8,Down,0.868449847921021,0.978785689255249
733,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.873657661831613,0.983119046377823
734,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.875522928166217,0.983119046377823
735,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.876032818141057,0.983119046377823
736,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.877964802368271,0.983119046377823
737,WP_ARYLAMINE_METABOLISM,1,Up,0.880123735057777,0.983119046377823
738,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.880441774267661,0.983119046377823
739,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.880636333664498,0.983119046377823
740,WP_CHOLESTASIS,9,Down,0.887594940878526,0.988208244745919
741,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.888799317777143,0.988208244745919
742,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.893029007538532,0.988208244745919
743,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.893682161855885,0.988208244745919
744,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.894091097303123,0.988208244745919
745,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.894101639538707,0.988208244745919
746,WP_CILIARY_LANDSCAPE,182,Down,0.897857766939252,0.988208244745919
747,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.9001570112526,0.988208244745919
748,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.904470581276813,0.988208244745919
749,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.905030435508743,0.988208244745919
750,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.9053388384082,0.988208244745919
751,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.90537614279636,0.988208244745919
752,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.905978085270692,0.988208244745919
753,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Down,0.906053009003346,0.988208244745919
754,WP_TRYPTOPHAN_METABOLISM,17,Up,0.906394653124763,0.988208244745919
755,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Up,0.906615274916689,0.988208244745919
756,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.908506495651481,0.988208244745919
757,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.912263064704974,0.988208244745919
758,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.912398483419398,0.988208244745919
759,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.913332396671143,0.988208244745919
760,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.913601180801871,0.988208244745919
761,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Down,0.913952678847245,0.988208244745919
762,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.914320336573489,0.988208244745919
763,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.916289449269069,0.988208244745919
764,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.916864537928152,0.988208244745919
765,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.917662972466108,0.988208244745919
766,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Up,0.917875417676976,0.988208244745919
767,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.921912318571908,0.988208244745919
768,WP_VITAMIN_D_METABOLISM,6,Up,0.927643523624997,0.988208244745919
769,WP_NEPHROTIC_SYNDROME,26,Up,0.927660652520353,0.988208244745919
770,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.927758576862664,0.988208244745919
771,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.927850072889117,0.988208244745919
772,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.928045782301598,0.988208244745919
773,WP_B_CELL_RECEPTOR_SIGNALING,87,Up,0.929564244974283,0.988208244745919
774,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Down,0.930953840824616,0.988208244745919
775,WP_IL4_SIGNALING,50,Up,0.932012408681087,0.988208244745919
776,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.933424369206645,0.988208244745919
777,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.933857847894227,0.988208244745919
778,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.933923267610753,0.988208244745919
779,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.933951163303953,0.988208244745919
780,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.935482115996622,0.988208244745919
781,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.936360625507977,0.988208244745919
782,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.937695940849494,0.988208244745919
783,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Up,0.940061155007184,0.988208244745919
784,WP_NETRINUNC5B_SIGNALING,35,Down,0.941597609414283,0.988208244745919
785,WP_OREXIN_RECEPTOR_PATHWAY,114,Up,0.942416442477927,0.988208244745919
786,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.942569922773503,0.988208244745919
787,WP_CHOLESTEROL_METABOLISM,50,Up,0.942690774078834,0.988208244745919
788,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.945809001415123,0.990218814933346
789,WP_TCELL_RECEPTOR_SIGNALING,73,Up,0.948216022993806,0.991478887774719
790,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.949764281813795,0.991478887774719
791,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.950617939672489,0.991478887774719
792,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Up,0.953627500075131,0.992574022466245
793,WP_HIPPOYAP_SIGNALING,15,Up,0.954074181594827,0.992574022466245
794,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.956936225219633,0.992633674687081
795,WP_ESTROGEN_SIGNALING,21,Up,0.958936578833658,0.992633674687081
796,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.959001492610242,0.992633674687081
797,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.960065991051307,0.992633674687081
798,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.960147481697322,0.992633674687081
799,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.961684648072267,0.992978516470113
800,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.964992786913015,0.995148811504047
801,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.966548371195375,0.995508622017708
802,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Down,0.970341183176746,0.996030121487352
803,WP_RANKLRANK_SIGNALING,47,Down,0.971106304189261,0.996030121487352
804,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.971129139402696,0.996030121487352
805,WP_GLIOBLASTOMA_SIGNALING,65,Up,0.971883936724022,0.996030121487352
806,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.974081605025759,0.996965273157969
807,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.980203360567326,0.996965273157969
808,WP_GALANIN_RECEPTOR_PATHWAY,11,Up,0.980550969598775,0.996965273157969
809,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.98111392216574,0.996965273157969
810,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.981311804603435,0.996965273157969
811,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Down,0.9826257321916,0.996965273157969
812,WP_AXON_GUIDANCE,33,Up,0.982890128472766,0.996965273157969
813,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.985504071339273,0.996965273157969
814,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.985698670467976,0.996965273157969
815,WP_FOXP3_IN_COVID19,9,Up,0.987843158572498,0.996965273157969
816,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.98899390442098,0.996965273157969
817,WP_TP53_NETWORK,14,Down,0.989660973121772,0.996965273157969
818,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.989758878476937,0.996965273157969
819,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.990230309920025,0.996965273157969
820,WP_HISTONE_MODIFICATIONS,35,Up,0.990923059381254,0.996965273157969
821,WP_GLUCURONIDATION,7,Down,0.994311389468932,0.997146949326268
822,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.994531962151845,0.997146949326268
823,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.995192704585498,0.997146949326268
824,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.995938286357388,0.997146949326268
825,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.997662255477688,0.997662255477688
